Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/10/23
End: 07/03/23
Due: 07/03/24
Phase: N/A
Priority: Normal
Start: 10/03/22
End: 07/26/23
Due: 07/26/24
Phase: N/A
Priority: Normal
Start: 06/14/23
End: 09/20/23
Due: 09/20/24
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study of WPV01 Compared With Placebo in Patients With Mild/Moderate COVID-19 Infection | NCT05752175 | Westlake Pharmaceuticals (Hangzhou) Co., Ltd. | user2@example.com | None | 2023-03-10 | 2023-07-03 | 2024-07-03 | - | - | 2025-07-14 |
| Study of WPV01 in Healthy Subjects | NCT06205329 | Westlake Pharmaceuticals (Hangzhou) Co., Ltd. | user2@example.com | None | 2022-10-03 | 2023-07-26 | 2024-07-26 | - | - | 2025-07-14 |
| Phase III Clinical Study Evaluating the Efficacy and Safety of WPV01 in Patients With Mild/Moderate COVID-19 | NCT06197217 | Westlake Pharmaceuticals (Hangzhou) Co., Ltd. | user2@example.com | None | 2023-06-14 | 2023-09-20 | 2024-09-20 | - | - | 2025-07-14 |